Literature DB >> 11562756

Angiogenesis in the adipose tissue of tumor-bearing rabbits treated by cyclic plasma perfusion.

O Ishiko1, T Sumi, H Yoshida, Y Hyun, S Ogita.   

Abstract

The mechanisms of cancer cachexia have not been elucidated. We previously reported that cyclic plasma perfusion using non-coated charcoal was effective in cancer cachexia. In the present study we investigated the angiogenic effect of cyclic plasma perfusion on adipose tissue. Twenty rabbits were divided into two groups, i.e., tumor-bearing rabbits subjected to cyclic plasma perfusion (n=10, PP group), and tumor-bearing rabbits subjected to sham-perfusion (n=10, SP group). The changes in body weight, total body fat, and expression of angiogenic factors were investigated. Loss of body weight and total body fat was significantly suppressed in the PP group. Apoptosis of adipocytes was seen in both groups only in the early stage of tumor bearing. Lipolytic activity in the PP group showed a lower ratio than that in the SP group. In the PP group, increased microvessel density and expression of vascular endothelial growth factor (VEGF) and platelet-derived endothelial cell growth factor (PD-ECGF) were seen at 40 days after transplantation. Similar findings were not seen in the SP group. These results suggest that cyclic plasma perfusion not only decreased lipolytic activity but induced angiogenesis in the adipose tissue.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11562756     DOI: 10.3892/ijo.19.4.785

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  2 in total

1.  Endothelial differentiation in multipotent cells derived from mouse and human white mature adipocytes.

Authors:  Medet Jumabay; Raushan Abdmaulen; Sumithra Urs; Sepideh Heydarkhan-Hagvall; Gregorio D Chazenbalk; Maria C Jordan; Kenneth P Roos; Yucheng Yao; Kristina I Boström
Journal:  J Mol Cell Cardiol       Date:  2012-09-18       Impact factor: 5.000

2.  Combined treatment of carfilzomib and z-VAD-fmk inhibits skeletal proteolysis and apoptosis and ameliorates cancer cachexia.

Authors:  Qiang Wang; Chunhong Li; Xudong Peng; Qingjie Kang; Dawei Deng; Liuping Zhang; Yueyong Zheng; Chaoyi Wang; Zhongpeng Qiao; Dunwei Guo; Song You; Hua Tang
Journal:  Med Oncol       Date:  2015-03-04       Impact factor: 3.064

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.